AI
RPRX icon

AdvisorShares Investments’s Royalty Pharma RPRX Stock Holding History

AdvisorShares Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,081
Closed -$461K – 345
2025
Q3 		$461K Sell
13,081
-166
-1% -$6.01K 0.08% 182
2025
Q2 		$477K Sell
13,247
-2,353
-15% -$78K 0.09% 114
2025
Q1 		$486K Buy
+15,600
New +$494K 0.1% 110
2024
Q2 		– Sell
-15,717
Closed -$477K – 319
2024
Q1 		$477K Hold
15,717
– – 0.08% 154
2023
Q4 		$441K Buy
+15,717
New +$432K 0.1% 158

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AdvisorShares Investments's RPRX Position: Q4 2025 in Review

AdvisorShares Investments sold out of Royalty Pharma (RPRX) in Q4 2025, closing a stake of 13,081 shares — an estimated $461K sold.

AdvisorShares Investments first reported a position in RPRX in Q4 2023 and held it in 5 quarters. The position peaked at $486K in Q1 2025. 540 funds tracked by Wall St. Rank hold RPRX as of Q4 2025.

  • AdvisorShares Investments reported no remaining Royalty Pharma position as of Q4 2025 after selling out during the quarter.
  • AdvisorShares Investments sold 13,081 Royalty Pharma shares in Q4 2025, an estimated $461K.
  • AdvisorShares Investments first reported a position in Royalty Pharma in Q4 2023 and held it in 5 quarters.
  • AdvisorShares Investments's Royalty Pharma position peaked at $486K in Q1 2025.
  • 540 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2025.

Based on AdvisorShares Investments's 13F filing for Q4 2025, filed 10 Feb 2026.